Back to Companies
AgomAb Therapeutics NV
AGMBNasdaqCIK: 0002020932
Recent Form 4 activity at AgomAb Therapeutics NV (AGMB) spans 12 filings across 5 insiders (all of them on the buy side). Purchases total $620.0K against $0 in sales — heavily weighted toward buying, for a net purchase of $620.0K. Epstein David R (Director) is the most active by dollar volume, and the single largest transaction was $103.5K by Epstein David R. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$620.0K
Purchases
$620.0K
Sales
$0
Unique Insiders
5
Recent Insider Trades
12 loaded
| Nov 19 | AGMB AgomAb Therapeutics NV | Epstein David R | Director | Buy | $27.9K |
| Nov 16 | AGMB AgomAb Therapeutics NV | Epstein David R | Director | Buy | $88.7K |
| Nov 6 | AGMB AgomAb Therapeutics NV | Epstein David R | Director | Buy | $103.5K |
| Oct 22 | AGMB AgomAb Therapeutics NV | Epstein David R | Director | Buy | $88.8K |
| Oct 9 | AGMB AgomAb Therapeutics NV | Epstein David R | Director | Buy | $44.5K |
| Oct 7 | AGMB AgomAb Therapeutics NV | Kemula Pierre Thadee Victor | Chief Financial Officer | Buy | $85.9K |
| Oct 7 | AGMB AgomAb Therapeutics NV | Epstein David R | Director | Buy | $86.3K |
| Oct 7 | AGMB AgomAb Therapeutics NV | Knotnerus Tim Jasper | Chief Executive Officer, Director | Buy | $94.4K |
| Sep 15 | AGMB AgomAb Therapeutics NV | Garcia Marino | Director | Award | $0 |
| Sep 15 | AGMB AgomAb Therapeutics NV | Garcia Marino | Director | Other | $0 |
| Sep 15 | AGMB AgomAb Therapeutics NV | Patel Naimish | Director | Other | $0 |
| Sep 15 | AGMB AgomAb Therapeutics NV | Patel Naimish | Director | Award | $0 |
12 filings